<DOC>
	<DOCNO>NCT00291772</DOCNO>
	<brief_summary>The purpose study see give study drug slow steady dose low blood sugar meal after-meal time .</brief_summary>
	<brief_title>Continuous Subcutaneous Infusion Pramlintide Insulin</brief_title>
	<detailed_description>The Diabetes Control Complications Trial ( DCCT ) show improve blood sugar control individual Type 1 diabetes ( T1DM ) stop delay onset long-term health problem . Insulin management aim control blood sugar near normal safely possible . However , possibility low blood sugar still remain . Low blood sugar major limit factor gain `` tight '' control blood sugar . Insulin ( hormone lower blood sugar ) glucagon ( hormone raise blood sugar ) play key role keep careful balance . There lack insulin failure glucagon work correctly diabetes . This lead high blood sugar right meal . It difficult normal blood sugar someone diabetes . This may due another hormone call amylin . This hormone may low people Type 1 diabetes . Amylin make pancreas ( part body make insulin ) . Amylin work lower blood sugar meal . Pramlintide name study drug . It man-made form amylin . It give shot ( skin ) like insulin . Pramlintide FDA approve . Studies adult show amylin lower high level glucagon make meal . This result improve `` meal '' high blood sugar overall blood sugar control . Currently , drug give separate shot insulin . When give shot ( one dose shot give ) child young adult , seem cause low blood sugar right meal . The `` slowing '' food digestion may cause low blood sugar pramlintide use . Another possible cause low blood sugar may way drug give ( instant shot versus slow infusion pump ) .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Pramlintide</mesh_term>
	<mesh_term>Islet Amyloid Polypeptide</mesh_term>
	<criteria>These child subject Texas Children 's Hospital Diabetes Care Center . The subject must 1 . 1322 year age time enrollment . 2 . Have diagnose diabetes least 1 year good control ( HbA1C le equal 8.5 % ) . 3 . Be continuous subcutaneous insulin infusion use insulin pump . 4 . Subjects must otherwise healthy except T1DM treat hypothyroidism . 5 . Menstruating woman must negative pregnancy test . 6 . Hemoglobin equal great 12 g/dL study . 7 . Weight 44 kg . 1 . Age great 23 year less 13 year time study 2 . Any chronic disease : leukemia , asthma , inflammatory bowel disease , cystic fibrosis , juvenile rheumatoid arthritis , etc treatment might directly indirectly affect glucose homeostasis , except diabetes hypothyroidism stable medication 3 . Anemia ( hemoglobin le 12mg/dl ) 4 . Lack supportive family environment 5 . Positive pregnancy test menstruate young woman 6 . Evidence history chemical abuse 7 . Hgb A1C great 8.5 % diabetic subject 8 . BMI &gt; 90 % tile age &lt; 10 % tile age 9 . Weight le 44 kg .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>22 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Type 1 Diabetes</keyword>
	<keyword>hypoglycemia</keyword>
	<keyword>hyperglycemia</keyword>
</DOC>